Research in the UAE

2019 MENACTRIMS MS Diagnosis and Treatment Guidelines

Published on Fri, 18 Oct 2019

Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines

The 2019 MENACTRIMS guidelines offer revised diagnostic and treatment recommendations for multiple sclerosis (MS) to reflect advancements in diagnostic criteria and therapies. Diagnosis emphasizes proving dissemination in space and time while excluding alternative explanations, guided by clinical and laboratory findings. Treatment algorithms address acute relapses, radiologically isolated syndrome, clinically isolated syndrome, relapsing-remitting MS, and progressive MS. These practical, evidence-based guidelines aim to improve patient outcomes through informed diagnostic and therapeutic decisions.

Related research

Learn More
Switching from Fingolimod/Natalizumab to Cladribine Without Rebound
Fri, 1 Dec 2023

Switching from Fingolimod/Natalizumab to Cladribine Without Rebound

Learn More
Learn More
Adherence Challenges for High-Efficacy MS Therapies
Fri, 22 May 2020

Adherence Challenges for High-Efficacy MS Therapies

Learn More
Learn More
Living with MS: A Biopsychosocial Perspective
Tue, 17 Aug 2021

Living with MS: A Biopsychosocial Perspective